Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: AGISOL LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-08-18 to 2022-09-25
Current total value of award: $855193.2
Description: EO14042 STREAMLINE PROCESS AND ENHANCE NEW DRUG REVIEW